Top Philadelphia, PA Pharmaceutical Companies (43)
Don't see your company?
Create a company profile
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for pro-innovation/pro-patient policies.
At Verrica Pharmaceuticals, we are dedicated to easing the strain of hard-to-treat viral skin infections affecting millions of underserved patients. We are initially developing a topical therapy for the treatment of molluscum contagiosum, a highly contagious and primarily pediatric viral skin disease, and common warts. There is currently no FDA-approved treatment nor is there an established standard of care for either of these diseases, resulting in significant undertreated populations in two of the largest unmet needs in dermatology. Headquartered in West Chester, Pennsylvania, Verrica was founded in 2013. We are led by a seasoned management team with extensive pharmaceutical industry experience ranging from drug development through commercialization and collectively launched more than 50 products.
Interius is an early-stage biotechnology company expanding the potential of cell and gene therapy by developing next-generation delivery technology based on inventions from the laboratory of Dr. Saar Gill at the University of Pennsylvania.
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 41,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue.
Pharmaceutical manufacturers, payers and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance and Exchange, enables the discovery of RWD across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy.
Medical jobs for medical experts. On-demand physician-only consulting marketplace. Source and secure physician talent within your budget.
Evolution Health Group is a full-service healthcare communications agency which has broad strategic capabilities and consists of 3 main divisions, Evolution Medical Communications (with expertise with respect to delivering P2P engagement strategy from pre-launch to LOE), Maestro360 (with expertise in program execution of meetings, events and conventions), BluLava (with expertise with respect to optimizing the customer engagement experience) and Darwin Academy (dedicated to providing novel, interactive peer to peer education). Evolution has proven success in partnering with pharmaceutical customers to launch new products leveraging market insights to drive critical brand planning decisions and maximize outcomes throughout each product’s life cycle. We value creating strong strategic partnerships with our customers by better understanding their challenges and opportunities through ongoing and evolutionary account management best practices. By adhering to the highest possible ethical standards and industry guidelines along with unparalled dedication to our employees and value-added partners, Evolution will work with our customers to help them evolve in order to deliver maximum physician engagement success in the ever-changing pharmaceutical environment. Evolution's focus on innovation has resulted in our creating novel engagement initiatives and proprietary digital offerings that were custom-made with our pharmaceutical clients in mind. Contact us to learn more!
CoJourney CO. is reimagining cell and gene therapy CDMO services globally. Our platform is built on High Purity, High Yield, On Time Supply and Significantly Reduced Costs. We provide process development and clinical and commercial mfg. through a range of platform technologies, including: (1) Plasmids, (2) mRNA, (3) AAV / adenovirus, (4) Lentivirus, (5) Retrovirus, (6) Custom Viral Vectors. We have proprietary high-purity, high-yield, streamlined and cost-effective processes and our facilities are compliant under US FDA, EU EMA and China NMPA Plasmid, mRNA, and Viral Vector development, manufacturing and import/export regulations. Plasmids are manufactured in a multi-product cGMP facility that includes multiple upstream suites, downstream suites and a fill-finish suite with an isolator and filler. The facility includes 30L disposable fermenters for plasmid production. Viral Vectors are manufactured in a cGMP viral vector facility that includes multiple upstream cell culture, upstream viral vector production suites, downstream processing and fill-finish suites. The facility includes 500L and 2,000L disposable bioreactors for viral vector production. CoJourney’s Process Development labs allow separate, client specific project rooms and are equipped with state of the art and large-scale equipment. The analytical development and Quality Control laboratories provide state of the art analytical equipment are focused on analytical development and performing all stages of release testing for plasmids and viral vectors. CoJourney is currently manufacturing AAV-based gene therapies that have been approved for use in global clinical trials: 1) rAAV based gene therapy for Neurovascular Age-Related Macular Degeneration (wet AMD) in USA 2) AAV based gene therapy for Spinal Muscular Atrophy (SMA) in China Please contact us to discuss how our innovative approaches and timely, cost-effective solutions can address your needs. Please contact us for more information.
Diverse Biotech is an innovative biopharmaceutical research company committed to discovering
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
VirtualScopics provides imaging solutions for clinical trials in the pharmaceutical, biotechnology, and medical device industries.
Amyndas is a pharmaceutical company
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Frontida BioPharm is a Minority-Owned Contract Development & Manufacturing Organization. We work collaboratively with our clients to bring new and improved products to the pharmaceutical market. By leveraging our team's vast knowledge and experience we are able to improve the success of our client's business and product development efforts. Frontida was launched by founding management team members of Frontage Laboratories. Having 15 years of success in the business Frontage remains a thriving CRO that has become a full service R&D organization located in PA, NJ, and China. With strong record of FDA compliance and quality service to global pharmaceutical and biotechnology companies, the Frontage team easily founded Frontida. While Frontage and Frontida remain affiliates, they are separate business entities.
Elevate Healthcare is a strategic communications agency specializing in shaping and translating product objectives into actionable sales and marketing strategies that drive commercial results for our pharmaceutical, biotech, and medical device clients. Early on, Elevate recognized that identifying the best solutions for its clients could be achieved more efficiently and successfully with a leaner, more experienced senior team of strategists who bring immediate value in a highly focused manner. This requires top people from multiple disciplines all working together to provide a comprehensive view of the complexities of a dynamic healthcare landscape to more quickly identify business and brand opportunities that can have a significant impact on a client’s business, then translate, transform, and elevate the promise of those opportunities into real-world success. This is particularly true for challenger brands, an area of expertise for Elevate.
Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer. Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these therapies to harness the body's own immune system to find and destroy diseased cells. Our SPEAR TCR therapies offer promise to patients that often have no other options. We are working hard to make that promise a reality.
Jenrin Discovery is a biopharmaceutical Company.
Lannett Company, Inc. develops, manufactures and distributes generic prescription pharmaceutical products in tablet.
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Work Your Passion. Live Your Purpose.
